Devices › Implant, intragastric for morbid obesity
Device brand name · Implant intragastric for morbid obesity
Realize Adj Gastric Band-C: medical device reports filed with FDA
524 reports name it, 2009–2019. Manufacturer given most often on reports: Obtech Medical Sarl. Product code LTI.
- 524
- device reports naming the brand
- 0% of all MAUDE reports · about 30 a year
- 0
- reports, 12 months to August 2026
- 0 in the 12 months before
- 60.1%
- classified as malfunction
- 60.3% across the product code
- 0%
- classified as death, as reported
- 0 reports · not verified by FDA
FDA's MAUDE database holds 524 reports that name the brand "Realize Adj Gastric Band-C" (implant intragastric for morbid obesity), received between January 2009 and June 2019; the manufacturer given most often on reports is Obtech Medical Sarl. Spellings of one product vary from report to report.
0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (60.1%) and injury (39.9%); across all implant, intragastric for morbid obesity reports (product code LTI) death is recorded in 1.1% and malfunction in 60.3%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are disconnection (17.7%), migration or expulsion of device (11.1%) and insufficient device problem information (9.9%). The patient problems coded most often are surgical procedure, additional, erosion and migration. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
No report naming Realize Adj Gastric Band-C was received in the five years to August 2026; the latest was received in June 2019.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 17,678 reports carrying product code LTI. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Disconnection | 93 | 17.7% | 2.1% |
| Migration or expulsion of device | 58 | 11.1% | 3% |
| Insufficient device problem information | 52 | 9.9% | 5.9% |
| Device slipped | 47 | 9% | 9.2% |
| Detachment of device component | 40 | 7.6% | 0.9% |
| Leak/splashthe device leaked | 30 | 5.7% | 23.6% |
| Fluid/blood leak | 25 | 4.8% | 19.1% |
| Breakthe device broke | 20 | 3.8% | 4.2% |
| Filling problem | 19 | 3.6% | 0.3% |
| Malposition of device | 19 | 3.6% | 0.3% |
| Device operates differently than expectedthe device behaved unexpectedly | 13 | 2.5% | 0.9% |
| Difficult to removethe device was hard to remove | 13 | 2.5% | 0.3% |
| Kinkedthe tube or line kinked | 12 | 2.3% | 0.4% |
| Torn material | 12 | 2.3% | 0.2% |
| Extrusion | 11 | 2.1% | 0.3% |
| Improper or incorrect procedure or method | 10 | 1.9% | 0.2% |
| Device dislodged or dislocated | 9 | 1.7% | 0.2% |
| Retraction problem | 9 | 1.7% | 0.1% |
| Device tipped over | 8 | 1.5% | 0.1% |
| Material erosion | 8 | 1.5% | 1.3% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Surgical procedure, additional | 58 | 11.1% |
| Erosion | 32 | 6.1% |
| Migrationthe device moved from where it was placed | 29 | 5.5% |
| Surgical procedure | 23 | 4.4% |
| Vomitingbeing sick | 20 | 3.8% |
| Painpain, site not specified | 18 | 3.4% |
| Abdominal painstomach or belly pain | 17 | 3.2% |
| Failure of implant | 15 | 2.9% |
| Hospitalization required | 15 | 2.9% |
| Other (for use when an appropriate patient code cannot be identified) | 12 | 2.3% |
| Obstruction/occlusion | 9 | 1.7% |
| Therapeutic response, decreased | 6 | 1.1% |
| Inflammationinflammation | 5 | 1% |
| Nauseafeeling sick | 5 | 1% |
| Discomfortdiscomfort | 4 | 0.8% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Realize Adj Gastric Band-C | Product code LTI | All MAUDE reports |
|---|---|---|---|
| Reports | 524 | 17,678 | 26,136,888 |
| Share of that pool | — | 3% | 0% |
| Classified as death, per 1,000 reports | 0 | 11 | 9 |
| Classified as injury | 39.9% | 38.1% | 36.2% |
| Classified as malfunction | 60.1% | 60.3% | 62.3% |
| Filed by the manufacturer | 99.6% | 96.2% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code LTI
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Lap-Band Adjustable Gastric Banding System | 2,199 | 0 | 2% |
| Lap-Band Adjustable Gastric Banding System Unk Size | 1,781 | 0 | 2% |
| Lap-Band Adjustable Gastric Banding System 9 75cm | 1,513 | 0 | 0.1% |
| Lap-Band System | 1,357 | 0 | 2% |
| Lap-Band Adjustable Gastric Banding System 10 0cm | 1,187 | 0 | 0.4% |
| Spatz3 Adjustable Balloon System | 906 | 125 | 0.6% |
| Orbera Intragastric Balloon System | 828 | 10 | 2.5% |
| Lap-Band Ap Adjustable Gastric Banding System Standard | 801 | 0 | 0.4% |
| Realize Adj Gastric Band Str | 527 | 0 | 0.2% |
| Lap-Band Adjustable Gastric Banding System Vg | 493 | 0 | 0.8% |
| Lap-Band Ap Adjustable Gastric Banding System Small | 448 | 0 | 1.1% |
| Lap-Band Ap Adjustable Gastric Banding System Large | 437 | 0 | 1.1% |
| ORBERA365 Intragastric Balloon System | 350 | 29 | 0.3% |
| Sagb Quickclose With Velocity Injection Port | 245 | 0 | 0% |
| Gen2 Adjustable Gastric Band - 11 Cm Unlocka | 196 | 0 | 0.5% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Realize Adj Gastric Band-C reports
How many FDA reports name Realize Adj Gastric Band-C?
524 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.
What kinds of events are reported?
malfunction (60.1%) and injury (39.9%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
disconnection (17.7%), migration or expulsion of device (11.1%), insufficient device problem information (9.9%), device slipped (9%) and detachment of device component (7.6%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (99.6%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Realize Adj Gastric Band-C was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.